202 filings
Page 4 of 11
8-K
eagrp9
28 Sep 18
Entry into a Material Definitive Agreement
4:00pm
8-K
pj5959ibd8vo026v03
7 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
zowxndd2yf eo3zok
3 Aug 18
Entry into a Material Definitive Agreement
9:30am
8-K
ck4fi xpdaq7pur01xfb
5 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K
8ei zrddz38zt
14 May 18
GT Biopharma Announces DR. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
4:01pm
8-K
oaz8p8585tdp zn7y
27 Apr 18
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
4:01pm
8-K/A
8qvf lzugxeug85n
15 Mar 18
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
9ejcdjnbeqp4eragm
21 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
vk4n uzlbw8594t
23 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
3p3sg15ah3vg8yt 2i
16 Jan 18
Geoffrey B. Davis Joins GT Biopharma’s Board of Directors
12:00am
8-K
piu7wwgfum4gnbb 6ob6
16 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
2pwdfvwdgqdx
12 Oct 17
GT Biopharma Announces Stock Sales Agreement with Holders of Converted Securities
12:00am
8-K
wgxghhrerp k3b
5 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
jmz gsfjzj0k6g
25 Jul 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
ss8s potqhl
26 Jun 17
Oxis Agrees to Acquire Georgetown Translational Pharmaceuticals, Appoints New Chief Executive Officer and Chief Medical Officer
12:00am
8-K
d4g55zk
3 Apr 17
Other Events
12:00am
8-K
a5edelnf vfb4
23 Mar 17
Unregistered Sales of Equity Securities
12:00am
8-K
nmg4rudq6v9ia72h2
2 Mar 17
Unregistered Sales of Equity Securities
12:00am
8-K
9hltxpqus eafjy
17 Feb 17
Unregistered Sales of Equity Securities
12:00am
8-K
xzyvmm h8ph
9 Feb 17
Unregistered Sales of Equity Securities
12:00am